Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe Location section has been updated with a large number of new sites across multiple regions and several sites removed, altering the map of where the study is conducted.SummaryDifference3%

- Check59 days agoChange DetectedPublication section wording updated to indicate publications are automatically filled from PubMed. Revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.6%

- Check66 days agoChange DetectedThe page no longer displays the government funding and operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedNo notable changes were detected on the page.SummaryDifference0.3%

- Check109 days agoChange DetectedThe page now includes a government funding notice about potential data/tansaction delays and states the NIH Clinical Center is open, along with a new software version (v3.2.0) replacing v3.1.0.SummaryDifference3%

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.